A detailed history of Edmond De Rothschild Holding S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 1,454 shares of VRTX stock, worth $681,518. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,454
Previous 1,583 8.15%
Holding current value
$681,518
Previous $644,000 5.75%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$407.69 - $446.08 $52,592 - $57,544
-129 Reduced 8.15%
1,454 $607,000
Q4 2023

Feb 12, 2024

SELL
$343.0 - $410.68 $41,503 - $49,692
-121 Reduced 7.1%
1,583 $644,000
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $49,712 - $53,281
-147 Reduced 7.94%
1,704 $592,000
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $9,432 - $10,557
-30 Reduced 1.59%
1,851 $651,000
Q1 2023

May 11, 2023

SELL
$283.23 - $323.1 $1.32 Million - $1.5 Million
-4,646 Reduced 71.18%
1,881 $592,000
Q4 2022

Feb 09, 2023

BUY
$285.76 - $321.48 $88,014 - $99,015
308 Added 4.95%
6,527 $1.88 Million
Q3 2022

Nov 09, 2022

SELL
$273.83 - $305.53 $1.88 Million - $2.1 Million
-6,867 Reduced 52.48%
6,219 $1.8 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $1.09 Million - $1.36 Million
-4,643 Reduced 26.19%
13,086 $3.69 Million
Q1 2022

May 10, 2022

SELL
$221.42 - $260.97 $511,480 - $602,840
-2,310 Reduced 11.53%
17,729 $4.63 Million
Q4 2021

Feb 10, 2022

SELL
$177.01 - $223.45 $1 Million - $1.27 Million
-5,677 Reduced 22.08%
20,039 $4.4 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $373,844 - $418,362
-2,061 Reduced 7.42%
25,716 $4.67 Million
Q2 2021

Aug 11, 2021

BUY
$187.49 - $221.1 $94,869 - $111,876
506 Added 1.86%
27,777 $5.6 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $402,239 - $468,865
1,943 Added 7.67%
27,271 $5.86 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $3.15 Million - $4.2 Million
15,211 Added 150.35%
25,328 $5.99 Million
Q2 2020

Aug 07, 2020

BUY
$225.48 - $295.8 $2.23 Million - $2.93 Million
9,903 Added 4627.57%
10,117 $2.94 Million
Q1 2018

May 15, 2018

SELL
$151.6 - $177.13 $1.76 Million - $2.05 Million
-11,600 Reduced 98.19%
214 $35,000
Q4 2017

Feb 14, 2018

SELL
$137.28 - $155.55 $1.94 Million - $2.2 Million
-14,150 Reduced 54.5%
11,814 $1.77 Million
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $3.85 Million - $4.21 Million
25,964
25,964 $3.95 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.